ProMIS Neurosciences Inc. Common Shares (ON) (PMN) Stock Forecast: StockMap's 2-Week Call
PMN stock forecast: StockMap's model leans Underperform on ProMIS Neurosciences Inc. Common Shares (ON) for the two weeks after the Nov 19 close, toward PMN trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 5 of 6 two-week windows on PMN since Aug 21; by chance, a call on the same dates was right 59% of the time.
ProMIS Neurosciences Inc. Common Shares (ON) last closed at $3.21, +2.56% on the session.
Against the IVW growth benchmark the position is +4.89% over the forecast window.
ProMIS Neurosciences Inc. Common Shares (ON)'s market cap is $28.88M as of November 19, 2026.
Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -33 (too close to call).
Where PMN sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 3 bullish and 12 bearish.
Agreement across those insights is 80%.
49 daily calls for PMN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks ProMIS Neurosciences Inc. Common Shares (ON) in the 8th percentile on return on equity, where 100 is best.
ProMIS Neurosciences Inc. Common Shares (ON) is classified under Health Care / Biotechnology.
StockMap tracks ProMIS Neurosciences Inc. Common Shares (ON) as the 330th largest of the 394 companies it covers in the Biotechnology industry, part of the Health Care sector.
Across that group the current two-week reads are 200 Moderate Underperform, 134 Neutral, 43 Strong Underperform and 17 Moderate Outperform.
On that composite ProMIS Neurosciences Inc. Common Shares (ON) ranks 267th of 394 in the group, against a group median of -0.27.